P-selectin genotype is associated with the development of cancer cachexia

EMBO Molecular Medicine

Volumn 4, Issue 6, 2012, Pages 462-471

  Tan, Benjamin H L ^a   Fladvad, Torill ^b   Braun, Theodore P ^c   Vigano, Antonio ^d   Strasser, Florian ^e   Deans, D A Christopher ^a   Skipworth, Richard J E ^a   Solheim, Tora S ^b   Damaraju, Sambasivarao ^f   Ross, James A ^a   Kaasa, Stein ^b   Marks, Daniel L ^c   Baracos, Vickie E ^f   Skorpen, Frank ^b   Fearon, Kenneth C H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e Kantonsspital St Gallen Division of Oncology Haematology   (Switzerland)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Animal models; Cachexia; Inflammation; P selectin; Polymorphisms

Indexed keywords

C REACTIVE PROTEIN; LIPOPOLYSACCHARIDE; PADGEM PROTEIN;

ADULT; AGED; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CANCER PATIENT; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; MUSCLE ATROPHY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; C-REACTIVE PROTEIN; CACHEXIA; COHORT STUDIES; DISEASE MODELS, ANIMAL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MICE; MIDDLE AGED; NEOPLASMS; P-SELECTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; WEIGHT LOSS;

EID: 84861847158     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201200231     Document Type: Article

References (52)

1. Antoun S, Rey A, Beal J, Montange F, Pressoir M, Vasson MP, Dupoiron D, Gourdiat-Borye A, Guillaume A, Maget B et al (2009) Nutritional risk factors in planned oncologic surgery: what clinical and biological parameters should be routinely used? World J Surg 33: 1633- 1640
2. Argiles JM, Moore-Carrasco R, Fuster G, Busquets S, Lopez-Soriano FJ (2003) Cancer cachexia: the molecular mechanisms. Int J Biochem Cell Biol 35: 405- 409
3. Borges E, Eytner R, Moll T, Steegmaier M, Campbell MA, Ley K, Mossmann H, Vestweber D (1997) The P-selectin glycoprotein ligand-1 is important for recruitment of neutrophils into inflamed mouse peritoneum. Blood 90: 1934- 1942
4. Braun T, Zhu XX, Szumowski M, Scott G, Grossberg A, Graham K, Khan A, Damaraju S, Colmers W, Baracos V et al (2011) Interleukin 1beta triggers muscle catabolism via a central nervous system-mediated pathway. Endocr Rev 32: P3- 528
5. Chen M, Geng JG (2006) P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp (Warsz) 54: 75- 84
6. Conneely KN, Boehnke M (2007) So many correlated tests, so little time!Rapid adjustment of P values for multiple correlated tests. Am J Hum Genet 81: 1158- 1168
7. Deans DA, Tan BH, Ross JA, Rose-Zerilli M, Wigmore SJ, Howell WM, Grimble RF, Fearon KC (2009a) Cancer cachexia is associated with the IL10-1082 gene promoter polymorphism in patients with gastroesophageal malignancy. Am J Clin Nutr 89: 1164- 1172
8. Deans DA, Tan BH, Wigmore SJ, Ross JA, de Beaux AC, Paterson-Brown S, Fearon KC (2009b) The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 100: 63- 69
9. Dehoux MJ, van Beneden RP, Fernandez-Celemin L, Lause PL, Thissen JP (2003) Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett 544: 214- 217
10. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Jr., Engstrom PF, Ezdinli EZ et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69: 491- 497
11. Doehner W, Pflaum CD, Rauchhaus M, Godsland IF, Egerer K, Cicoira M, Florea VG, Sharma R, Bolger AP, Coats AJ et al (2001) Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. Eur J Endocrinol 145: 727- 735
12. Dunlop LC, Skinner MP, Bendall LJ, Favaloro EJ, Castaldi PA, Gorman JJ, Gamble JR, Vadas MA, Berndt MC (1992) Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med 175: 1147- 1150
13. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G et al (2008) Cachexia: a new definition. Clin Nutr 27: 793- 799
14. Fearon KC, Preston T (1990) Body composition in cancer cachexia. Infusionstherapie 17, 63- 66
15. Fearon KC, Voss AC, Hustead DS (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83: 1345- 1350
16. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, Macdonald N, Mantovani G et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12: 489- 495
17. Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF (2009) Estimation of cachexia among cancer patients based on four definitions. J Oncol 2009: 693458
18. Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM (2005) Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 54: 540- 545
19. Hill AG, Jacobson L, Gonzalez J, Rounds J, Majzoub JA, Wilmore DW (1996) Chronic central nervous system exposure to interleukin-1 beta causes catabolism in the rat. Am J Physiol 271: R1142- R1148
20. Jatoi A, Qi Y, Kendall G, Jiang R, McNallan S, Cunningham J, Mandrekar S, Yang P (2009) The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer. Support Care Cancer 18: 1299- 1304
21. Johnston GI, Bliss GA, Newman PJ, McEver RP (1990) Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes. J Biol Chem 265: 21381- 21385
22. Keren A, Tamir Y, Bengal E (2006) The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol Cell Endocrinol 252: 224- 230
23. Knoll S, Zimmer S, Hinney A, Scherag A, Neubauer A, Hebebrand J (2008) Val103Ile polymorphism of the melanocortin-4 receptor gene (MC4R) in cancer cachexia. BMC Cancer 8: 85
24. Le Roux CW, Ghatei MA, Gibbs JS, Bloom SR (2005) The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension. Heart 91: 241- 242
25. Lecker SH, Goldberg AL, Mitch WE (2006) Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17: 1807- 1819
26. Mahmoud FA, Rivera NI (2002) The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 4: 250- 255
27. Maltoni M, Nanni O, Scarpi E, Rossi D, Serra P, Amadori D (2001) High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol 12: 289- 300
28. Marks DL, Ling N, Cone RD (2001) Role of the central melanocortin system in cachexia. Cancer Res 61: 1432- 1438
29. McMillan DC, Canna K, McArdle CS (2003) Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90: 215- 219
30. Miller MA, Kerry SM, Dong Y, Strazzullo P, Cappuccio FP (2004) Association between the Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in a multiethnic population in South London. Thromb Haemost 92: 1060- 1065
31. Nicholson JR, Kohler G, Schaerer F, Senn C, Weyermann P, Hofbauer KG (2006) Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice. J Pharmacol Exp Ther 317: 771- 777
32. O'Gorman P, McMillan DC, McArdle CS (1999) Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr Cancer 35: 127- 129
33. Ott J, Hoh J (2003) Set association analysis of SNP case-control and microarray data. J Comput Biol 10: 569- 574
34. Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF (1995) The validity of self-reports of past body weights by U.S. adults. Epidemiology 6: 61- 66
35. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559- 575
36. Ramos EJ, Middleton FA, Laviano A, Sato T, Romanova I, Das UN, Chen C, Qi Y, Meguid MM (2004) Effects of omega-3 fatty acid supplementation on tumor-bearing rats. J Am Coll Surg 199: 716- 723
37. Ryden M, Arner P (2007) Fat loss in cachexia-is there a role for adipocyte lipolysis? Clin Nutr 26: 1- 6
38. Sato T, Meguid MM, Fetissov SO, Chen C, Zhang L (2001) Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats. Am J Physiol Regul Integr Comp Physiol 281: R1907- R1916
39. Skipworth RJ, Stewart GD, Bhana M, Christie J, Sturgeon CM, Guttridge DC, Cronshaw AD, Fearon KC, Ross JA (2010) Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine. Int J Oncol 36: 973- 982
40. Stephens NA, Gallagher IJ, Rooyackers O, Skipworth RJ, Tan BH, Marstrand T, Ross JA, Guttridge DC, Lundell L, Fearon KC et al (2010) Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med 2: 122
41. Stunkard AJ, Albaum JM (1981) The accuracy of self-reported weights. Am J Clin Nutr 34: 1593- 1599
42. Tan BH, Ross JA, Kaasa S, Skorpen F, Fearon KC (2011) Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review. J Genet 90: 165- 177
43. Tisdale MJ (2002) Cachexia in cancer patients. Nat Rev Cancer 2: 862- 871
44. Tisdale MJ (2004) Cancer cachexia. Langenbecks Arch Surg 389: 299- 305
45. Tisdale MJ (2009) Mechanisms of cancer cachexia. Physiol Rev 89: 381- 410
46. Tisdale MJ, Brennan RA, Fearon KC (1987) Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer 56: 39- 43
47. Vary TC, Dardevet D, Grizard J, Voisin L, Buffiere C, Denis P, Breuille D, Obled C (1998) Differential regulation of skeletal muscle protein turnover by insulin and IGF-I after bacteremia. Am J Physiol 275: E584- E593
48. Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Wu KK, Boerwinkle E (2006) P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study. Atherosclerosis 186: 74- 79
49. Wagenmakers AJ, van Riel NA, Frenneaux MP, Stewart PM (2006) Integration of the metabolic and cardiovascular effects of exercise. Essays Biochem 42: 193- 210
50. Watson ML, Kingsmore SF, Johnston GI, Siegelman MH, Le Beau MM, Lemons RS, Bora NS, Howard TA, Weissman IL, McEver RP et al (1990) Genomic organization of the selectin family of leukocyte adhesion molecules on human and mouse chromosome 1. J Exp Med 172: 263- 272
51. Wisse BE, Frayo RS, Schwartz MW, Cummings DE (2001) Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 142: 3292- 3301
52. Zhang D, Zheng H, Zhou Y, Tang X, Yu B, Li J (2007) Association of IL-1beta gene polymorphism with cachexia from locally advanced gastric cancer. BMC Cancer 7: 45